Your browser doesn't support javascript.
loading
PaTH Forward: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of TransCon PTH in Adult Hypoparathyroidism.
Khan, Aliya A; Rejnmark, Lars; Rubin, Mishaela; Schwarz, Peter; Vokes, Tamara; Clarke, Bart; Ahmed, Intekhab; Hofbauer, Lorenz; Marcocci, Claudio; Pagotto, Uberto; Palermo, Andrea; Eriksen, Erik; Brod, Meryl; Markova, Denka; Smith, Alden; Pihl, Susanne; Mourya, Sanchita; Karpf, David B; Shu, Aimee D.
Afiliación
  • Khan AA; Department of Endocrinology and Metabolism and Geriatrics, McMaster University, Hamilton, Ontario L8S 4L8, Canada.
  • Rejnmark L; Department of Endocrinology and Internal Medicine, Aarhus University Hospital, 8200 Aarhus N, Denmark.
  • Rubin M; Metabolic Bone Disease Unit, Columbia University, New York, New York 10027, USA.
  • Schwarz P; Department of Endocrinology, Rigshospitalet, Copenhagen and Faculty of Health Sciences, Copenhagen University, 2200 Copenhagen N, Denmark.
  • Vokes T; Section of Endocrinology, Diabetes and Metabolism, University of Chicago, Chicago, Illinois 60637, USA.
  • Clarke B; Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic, Rochester, Minnesota 55905, USA.
  • Ahmed I; Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA.
  • Hofbauer L; Universitätsklinikum Dresden, 01307 Dresden, Germany.
  • Marcocci C; University of Pisa, 56126 Pisa, Italy.
  • Pagotto U; Division of Endocrinology and Diabetes Prevention and Care, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Department of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum University of Bologna, 40126 Bologna, Italy.
  • Palermo A; Unit of Endocrinology and Diabetes, Campus Bio-Medico University, 00128 Rome, Italy.
  • Eriksen E; Oslo University Hospital, Institute of Clinical Medicine, 0372 Oslo, Norway.
  • Brod M; The Brod Group, Mill Valley, California 94941, USA.
  • Markova D; Ascendis Pharma Inc , Palo Alto, California 94301, USA.
  • Smith A; Ascendis Pharma Inc , Palo Alto, California 94301, USA.
  • Pihl S; Ascendis Pharma A/S, 2900 Hellerup, Denmark.
  • Mourya S; Ascendis Pharma Inc , Palo Alto, California 94301, USA.
  • Karpf DB; Ascendis Pharma A/S, 2900 Hellerup, Denmark.
  • Shu AD; Ascendis Pharma Inc , Palo Alto, California 94301, USA.
J Clin Endocrinol Metab ; 107(1): e372-e385, 2022 01 01.
Article en En | MEDLINE | ID: mdl-34347093
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Hormona Paratiroidea / Terapia de Reemplazo de Hormonas / Hipoparatiroidismo Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Clin Endocrinol Metab Año: 2022 Tipo del documento: Article País de afiliación: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Hormona Paratiroidea / Terapia de Reemplazo de Hormonas / Hipoparatiroidismo Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Clin Endocrinol Metab Año: 2022 Tipo del documento: Article País de afiliación: Canadá